Sangamo Therapeutics
SGMO
#10622
Rank
โ‚น2.95 B
Marketcap
โ‚น7.13
Share price
0.00%
Change (1 day)
-88.52%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -โ‚น9.92 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are โ‚น34.55 Million. In 2025 the company made an earning of -โ‚น10.41 Billion a decrease over its 2024 earnings that were of -โ‚น9.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น9.92 Billion-4.65%
2025 -โ‚น10.41 Billion9.71%
2024 -โ‚น9.49 Billion-17.27%
2023 -โ‚น11.46 Billion-40.88%
2022 -โ‚น19.39 Billion9.79%
2021 -โ‚น17.66 Billion41.52%
2020 -โ‚น12.48 Billion23.17%
2019 -โ‚น10.13 Billion36.33%
2018 -โ‚น7.43 Billion36.89%
2017 -โ‚น5.43 Billion-22.32%
2016 -โ‚น6.99 Billion54.86%
2015 -โ‚น4.52 Billion75.62%
2014 -โ‚น2.57 Billion0.13%
2013 -โ‚น2.57 Billion
2011 -โ‚น3.45 Billion43.66%
2010 -โ‚น2.41 Billion28.52%
2009 -โ‚น1.87 Billion-23.55%
2008 -โ‚น2.45 Billion2.45%
2007 -โ‚น2.39 Billion19.5%
2006 -โ‚น2 Billion50.78%
2005 -โ‚น1.33 Billion75%
2004 -โ‚น0.76 Billion-33.25%
2003 -โ‚น1.14 Billion-62.27%
2002 -โ‚น3.01 Billion102.82%
2001 -โ‚น1.49 Billion23.21%
2000 -โ‚น1.21 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.523 T-23,855.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น990.63 B-9,424.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น97.39 B-1,016.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-โ‚น96.02 Billion 803.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น188.27 Billion 1,672.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น740.54 B-7,070.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น108.30 B-1,119.42%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น14.35 B-235.16%๐Ÿ‡บ๐Ÿ‡ธ USA